Amita Goel

Amita Goel is a prominent figure in the biotech industry with over 30 years of experience. She is the Founder and CEO of Celltheon Corporation, a company she established in January 2012 to develop cutting-edge technologies for generating biotherapeutics more efficiently.12

Professional Background

Amita has held several key positions throughout her career:

• Founder and CEO of Celltheon Corporation (2012-present)
• Board member of the Amgen Bioprocessing Center Advisory Board (ABCAB) at Keck Graduate Institute (2014-present)
• Group leader of Upstream Process Development at Gilead Sciences (2010-2011)
• Manager and Scientist at Elan Pharmaceuticals (2002-2010)

Expertise and Contributions

Amita is known for her expertise in:

• Cell line development for next-generation biotherapeutics
• Process optimization for generating high-quality proteins
• Technology development for difficult-to-express proteins (DEPs)

At Celltheon, she has led the development of patented technologies, including the CHOK-1 derived SUPERCELL™ cell line and unique DNA and RNA vector elements.2

Education and Recognition

• MS in Microbiology from San Jose State University
• BS in Microbiology from Texas Tech University (graduated Cum Laude)
• Recipient of multiple industry awards, including Elan's Recognition Awards and Hybritech Annual R&D Recognition Awards2

Additional Roles and Interests

Amita is passionate about advancing biotechnology and frequently gives invited lectures at Keck Graduate Institute.3 She also mentors students in bioprocessing and serves as a Key Opinion Leader (KOL) at Pall, a Danaher company.1

Her LinkedIn username is amita-goel-698a0916, as mentioned in the query.2